Amalgamated Financial’s Akoya BioSciences AKYA Stock Holding History

Amalgamated Financial’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$24K	Buy	+2,189	New	+$25.4K	﹤0.01%	2682

Other funds holding AKYA

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Amalgamated Financial's AKYA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Akoya BioSciences (AKYA) in Q1 2022: 2,189 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #2682 among its holdings.

46 funds tracked by Wall St. Rank hold AKYA as of Q1 2022.

Amalgamated Financial held 2,189 shares of Akoya BioSciences worth $24K as of Q1 2022.
Akoya BioSciences was a new Amalgamated Financial position in Q1 2022.
Akoya BioSciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2682 holding.
46 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.